| Obesity |
1 |
1 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.95 |
| Biliary Disease |
0 |
0.93 |
| Liver |
0 |
0.83 |
| Liver Disease |
0 |
0.99 |
| Hepatic Fibrosis |
0 |
0.65 |
| Aminotransferase |
0 |
0.64 |
| Metabolic Syndrome |
0 |
0.61 |
| Hepatocellular Carcinoma |
0 |
0.53 |
| Nonalcoholic Steatohepatitis |
0 |
0.45 |
| Weight Management |
0 |
0.26 |
| Weight Loss |
0 |
0.25 |
| Metabolism |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.12 |
| Type 2 Diabetes Mellitus |
0 |
0.12 |
| Lipids Management |
0 |
0.11 |
| Steatosis |
0 |
0.1 |
| Cardiometabolic Risk Factors |
0 |
0.07 |
| Patient Safety |
0 |
0.06 |